Stephen Barker
Stock Analyst at Jefferies
(3.76)
# 2,043
Out of 5,099 analysts
121
Total ratings
46%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Stephen Barker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4543 Terumo Corporation | Reiterated: Buy | ¥3,500 → ¥2,700 | ¥2,384 | +13.26% | 5 | Oct 9, 2026 | |
| TYO: 4519 Chugai Pharmaceutical Co., Ltd. | Reiterated: Hold | ¥8,000 → ¥6,100 | ¥6,791 | -10.18% | 9 | Sep 29, 2026 | |
| TYO: 4506 Sumitomo Pharma Co., Ltd. | Reiterated: Buy | ¥2,400 → ¥2,700 | ¥1,940 | +39.18% | 11 | Sep 14, 2026 | |
| TYO: 4151 Kyowa Kirin Co., Ltd. | Downgraded: Hold | ¥2,800 → ¥2,600 | ¥2,461 | +5.65% | 6 | Sep 8, 2026 | |
| TYO: 4578 Otsuka Holdings Co., Ltd. | Reiterated: Buy | ¥12,700 → ¥14,000 | ¥12,015 | +16.52% | 13 | Sep 7, 2026 | |
| TYO: 6869 Sysmex Corporation | Reiterated: Hold | ¥1,700 → ¥2,100 | ¥1,947 | +7.89% | 5 | Aug 27, 2026 | |
| TYO: 7733 Olympus Corporation | Reiterated: Buy | ¥2,300 → ¥3,300 | ¥1,744 | +89.27% | 5 | Aug 27, 2026 | |
| TYO: 4502 Takeda Pharmaceutical Company Limited | Reiterated: Buy | ¥6,800 → ¥7,100 | ¥6,533 | +8.68% | 6 | Aug 21, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Downgraded: Hold | ¥3,100 → ¥3,000 | ¥2,891 | +3.79% | 14 | Jul 30, 2026 | |
| TYO: 2160 GNI Group Ltd. | Reiterated: Buy | ¥3,800 | ¥2,305 | +64.86% | 4 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥1,800 → ¥2,500 | ¥2,355 | +6.16% | 3 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥4,200 → ¥4,500 | ¥3,557 | +26.51% | 8 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥5,000 → ¥4,000 | ¥4,975 | -19.60% | 9 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥1,500 | ¥1,366 | +9.81% | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥1,500 → ¥2,800 | ¥2,533 | +10.54% | 7 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥1,900 → ¥1,700 | ¥1,795 | n/a | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥7,400 → ¥2,500 | ¥3,029 | n/a | 3 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥3,400 → ¥4,100 | ¥3,396 | n/a | 4 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥560 → ¥660 | ¥502 | n/a | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ¥320 | ¥252 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥2,700 | ¥1,121 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥3,600 | ¥3,795 | n/a | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $639.00 | n/a | 1 | Feb 1, 2019 |
Terumo Corporation
Oct 9, 2026
Reiterated: Buy
Price Target: ¥3,500 → ¥2,700
Current: ¥2,384
Upside: +13.26%
Chugai Pharmaceutical Co., Ltd.
Sep 29, 2026
Reiterated: Hold
Price Target: ¥8,000 → ¥6,100
Current: ¥6,791
Upside: -10.18%
Sumitomo Pharma Co., Ltd.
Sep 14, 2026
Reiterated: Buy
Price Target: ¥2,400 → ¥2,700
Current: ¥1,940
Upside: +39.18%
Kyowa Kirin Co., Ltd.
Sep 8, 2026
Downgraded: Hold
Price Target: ¥2,800 → ¥2,600
Current: ¥2,461
Upside: +5.65%
Otsuka Holdings Co., Ltd.
Sep 7, 2026
Reiterated: Buy
Price Target: ¥12,700 → ¥14,000
Current: ¥12,015
Upside: +16.52%
Sysmex Corporation
Aug 27, 2026
Reiterated: Hold
Price Target: ¥1,700 → ¥2,100
Current: ¥1,947
Upside: +7.89%
Olympus Corporation
Aug 27, 2026
Reiterated: Buy
Price Target: ¥2,300 → ¥3,300
Current: ¥1,744
Upside: +89.27%
Takeda Pharmaceutical Company Limited
Aug 21, 2026
Reiterated: Buy
Price Target: ¥6,800 → ¥7,100
Current: ¥6,533
Upside: +8.68%
Daiichi Sankyo Company, Limited
Jul 30, 2026
Downgraded: Hold
Price Target: ¥3,100 → ¥3,000
Current: ¥2,891
Upside: +3.79%
GNI Group Ltd.
Jul 13, 2026
Reiterated: Buy
Price Target: ¥3,800
Current: ¥2,305
Upside: +64.86%
May 29, 2026
Reiterated: Hold
Price Target: ¥1,800 → ¥2,500
Current: ¥2,355
Upside: +6.16%
May 29, 2026
Reiterated: Buy
Price Target: ¥4,200 → ¥4,500
Current: ¥3,557
Upside: +26.51%
May 28, 2026
Reiterated: Hold
Price Target: ¥5,000 → ¥4,000
Current: ¥4,975
Upside: -19.60%
Apr 30, 2026
Reiterated: Hold
Price Target: ¥1,500
Current: ¥1,366
Upside: +9.81%
Mar 24, 2026
Reiterated: Buy
Price Target: ¥1,500 → ¥2,800
Current: ¥2,533
Upside: +10.54%
Aug 8, 2025
Downgraded: Hold
Price Target: ¥1,900 → ¥1,700
Current: ¥1,795
Upside: n/a
Oct 25, 2024
Reiterated: Hold
Price Target: ¥7,400 → ¥2,500
Current: ¥3,029
Upside: n/a
Oct 21, 2024
Reiterated: Hold
Price Target: ¥3,400 → ¥4,100
Current: ¥3,396
Upside: n/a
Sep 11, 2024
Reiterated: Hold
Price Target: ¥560 → ¥660
Current: ¥502
Upside: n/a
Sep 9, 2024
Upgraded: Buy
Price Target: ¥320
Current: ¥252
Upside: n/a
Aug 1, 2024
Reiterated: Hold
Price Target: ¥2,700
Current: ¥1,121
Upside: n/a
Jul 30, 2024
Reiterated: Hold
Price Target: ¥3,600
Current: ¥3,795
Upside: n/a
Feb 1, 2019
Upgraded: Buy
Price Target: n/a
Current: $639.00
Upside: n/a